The percentage of adult patients with chronic liver disease who have received a hepatitis A vaccine
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.9 Care Setting1.20 Testing Data Sources
-
1.14 Numerator
Patients with chronic liver disease who have received a hepatitis A vaccine.
-
1.15 Denominator
All patients, ages 18 and older, diagnosed with chronic liver disease
-
Exclusions
Specific Exclusions: 1. Patients with a previous history of viral hepatitis 2. Patients who report an allergy to Hepatitis A vaccine A. General exclusions: 1. Evidence of metastatic disease or active treatment of malignancy (chemotherapy or radiation therapy) in the last 6 months; 2. Patients who have been in a skilled nursing facility in the last 3 months (this exclusion is included to avoid holding physicians who care for patients during a transitional period, e.g. temporary SNF placement, for their ongoing care; hence, the time limitation of 3 months).
-
Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed GI and GU Endorsement Maintenance ProjectInitial EndorsementLast UpdatedRemoval Date
-
StewardSteward Organization EmailSteward Organization Copyright
This information, including any attachments hereto, is the sole, exclusive, proprietary and confidential property of ActiveHealth Management, Inc., and is for the exclusive use of The National Quality Forum. Any use, copying, disclosure, dissemination or distribution by anyone other than the National Quality Forum is strictly prohibited.
-
-
-
Risk Adjustment
-
-
-
6.1.2 Current or Planned Use(s)6.1.3 Current Use(s)
-